Clinical Trial Update: Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated modafinil for reducing persistent fatigue in patients after cancer treatment; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Cancer-related Fatigue
• Chemotherapy-induced Fatigue

Drugs mentioned

• Modafinil (modafinil)

Snippet

Sponsor: University of Rochester | Conditions: Cancer, Fatigue | Phase 2 | Status: COMPLETED